
Investors hope for a repeat of Gilead’s Sovaldi success

Investors hope for a repeat of Gilead’s Sovaldi success

Company is targeting a treatment for glioblastoma; Phase I to begin next year

Leading CRO looks to better trial recruitment, outcomes research

Is the accelerated-approval process providing a net benefit to patients?

CEIV Pharma certification; expanded temperature regimes and better calibration capabilities

Oncology, obesity control and respiratory therapy are the first targets

Firm has quintupled its Indianapolis facility over two years

Pharma traceability company will expand global presence

August, December and February meetings target unresolved technical issues

GAO report notes FDA’s 99% acceptance rate for ‘expanded access’, but legislators press on

Managing physician office drug inventory

More serialization options, especially for low-volume pharma manufacturers struggling with the November 2017 deadline

40,000-sq. ft. facility is near Dublin Airport

Completion scheduled for 2019

New DHL report sees transformational trends

Cellular and genetic therapies drive a ‘new paradigm’ for logistics

Novartis’ CTL019 (tisagenlecleucel) has helped nearly 80% of patients who failed chemotherapy for a form of leukemia

Late-June announcement gives industry some breathing room for installing product-serialization systems

Fourth annual meeting will occur Oct. 16-17

November 2018 becomes the deadline day for serializing pharma packages

40,000-sq. ft. facility is near Dublin Airport

Veeva survey finds a trend toward combined data capture, trial management and master files

Technology combines automated equipment with workflow and analytic software

The southern California region carves out a special place for genomics within biotechnology

More serialization options, especially for low-volume pharma manufacturers struggling with the November 2017 deadline